SI-BONE (SIBN) News
NASDAQ: SIBNHealth CareMedical/Dental InstrumentsUSD
23.73-0.02 (-0.08%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SIBN news summary
We found 9 recent headlines mentioning SI-BONE (SIBN): 1 in the past week and 8 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, SIBN is down 0.08% at $23.73. The most recent story, "SI-BONE To Present at Piper Sandler 38th Annual Healthcare Conference on December 1, 2026", was published by GlobeNewswire on Nov 19, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest SI-BONE headlines
- SI-BONE To Present at Piper Sandler 38th Annual Healthcare Conference on December 1, 2026SAN JOSE, Calif., Nov. 19, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,…GlobeNewswire
- SiBone (SIBN) Hit a 52 Week High, Can the Run Continue?Si-Bone (SIBN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.NasdaqSIBN, GMED
- Healthcare Stocks Move Higher: SIBN Rallies 18%, NBIX Gains 16%, RMTI Climbs 16%, PTCT Up 13%(RTTNews) - Healthcare stocks moved higher following quarterly earnings reports, acquisition news and capital allocation updates. SI-BONE and Neurocrine Biosciences advanced after reporting…NasdaqNBIX, PTCT, RMTI, SIBN
- SI-Bone Q3 Loss Narrows As Revenue Rises 14.5%; Reaffirms FY26 Revenue Outlook(RTTNews) - SI-BONE, Inc. (SIBN) reported a narrower third-quarter loss as strong procedure volume growth lifted revenue.NasdaqSIBN, LEN.B
- SI-BONE (SIBN) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- SiBone Q3 Earnings Call Highlights4 Recent Earnings Winners Riding Fresh Momentum in MaySiBone (NASDAQ:SIBN) reported third-quarter 2026 revenue growth of 14.5% as procedure demand accelerated, active physician adoption expanded and…Nasdaq
- SI-BONE, Inc. Reports Financial Results for the Third Quarter 2026 and Reaffirms 2026 Revenue GuidanceDelivered ~20 % U.S. procedure volume growth in the third quarterGlobeNewswire
- SI-BONE To Present at UBS Global Healthcare Conference on November 10, 2026SAN JOSE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,…GlobeNewswire
- SI-BONE To Report Third Quarter 2026 Financial Results on November 2, 2026SAN JOSE, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ: SIBN), a global leader in developing procedural solutions to address clinical challenges associated with compromised bone,…GlobeNewswire